SEATTLE, August 03, 2021, (MEDGADGET) — Global Virology Testing Market Analysis
Overview
Virology testing refers to diagnostic procedures that aid in the early identification of diseases such as viral infections, hepatitis, RCV, sexually transmitted illness, HIV, and influenza. In order to establish the existence of a specific viral infection, virology testing looks for viral antibodies, antigens, and nucleic acids in a given sample. According to the reports, there are over a hundred infectious diseases.
Virology testing employs a variety of techniques to verify viral infections. Since a long time, a culture medium-based approach in which the virus is verified by colony development over culture has been utilized. However, this approach is generally accepted and simple to use, it is time-consuming, since it can take anything from a few days to weeks to confirm the presence of a specific virus. It is a severe restriction, particularly in viral pandemics, where a loss of time might lead to more extensive transmission and a delay in viral illness management.
*The Sample consists of Table of Content, Research framework of the actual report & research methodology adopted for it.
Download Free PDF Sample: https://www.coherentmarketinsights.com/insight/request-pdf/2037
Drivers
With the growing incidence of virus-based infections such as flu, hepatitis, AIDS, and STDs, Ebola, influenza-based bacterial infections, severe acute respiratory syndrome from coronavirus, hemorrhagic fever, and others around the world, the global virology testing market is expected to grow significantly over the forecast period. It is critical to diagnose a viral infection as soon as possible in order to begin therapy.
As per a factsheet published by the WHO (World Health Organization) in January 2018, all forms of influenza together generate yearly epidemics of three to five million cases with severe disease, resulting in nearly 650,000 fatalities globally each year. PCR-based methods are being utilized for influenza diagnosis, despite the widespread usage of fast diagnostic assays.
According to the World Health Organization’s Report on Global Sexually Transmitted Infection Surveillance, a projected 357 million new infections, or up to one million patients per day, were reported in 2012 for the four treatable sexually transmitted diseases of chlamydia, gonorrhea, syphilis, and trichomoniasis.
“Limited Time Offer”
Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2037
In addition, advancements in anti-viral therapy in terms of detecting techniques, medicines, and vaccines are projected to propel the global virology testing market forward. Novel vaccines and medications for treating virally resistant illnesses are being developed across the world. In Phase II studies, AiCuris’ experimental medication for HSV (Herpes Simplex Virus) proved to be extremely efficient when compared to existing conventional antiviral therapies for genital herpes. For the treatment of high-epidemic viral diseases including Ebola, Dengue Fever, and Malaria, much research has been performed across the world.
The global virology testing market development might be aided by new technology for identifying and treating viral illnesses. The nanoscale viral trap molecule technology, which is currently being researched, might be used to diagnose a viral illness. An ingenious adjustable gadget selectively captures viruses, detecting them 100 times more sensitively than current approaches. Another nanoparticle-based drug in development to cure viral disease is DRACO (Double-stranded RNA Activated Caspase Oligomerizer).
Regional Analysis
During the forecast period, North America is expected to lead the global virology testing market. In 2015, the Centers for Disease Control and Prevention (CDC) recorded 5,251 fatalities as a result of influenza illness.
As per the findings of the National Ambulatory Medical Care Survey: 2015 data, about 16.8 million individuals see a doctor for treatment of infectious and parasitic diseases in the U.S. Furthermore, according to a research by the Society for Risk Analysis, the GDP loss in the U.S. due to a viral pandemic breakout in 2016 was between US$ 34.4 billion and US$ 45.3 billion in 2015.
The U.S. has the best healthcare infrastructure and the greatest healthcare spending in the world, making it the most profitable market. Due to the spread of viral influenza and the world’s largest HIV patient population, Asia Pacific is anticipated to grow at a fast rate.
To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/2037
Competitive Landscape
Major companies contributing in the global virology testing market are Thermo Fisher Scientific Inc., Fujirebio Diagnostics Inc., Qiagen, Scienion AG, Hologic Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Diamedix Inc., Sequenom, Abbot HealthcareEiken Chemical Co Ltd., Siemens AG Grifols, Diasorin, bioMerieux SA, and Cepheid.
Key Developments
Hain Lifescience GmbH, a molecular diagnostics firm, was purchased by Bruker Corporation in 2018. The Bruker Corporation’s molecular diagnostic product range will be expanded as a result of this acquisition.
In the year 2018, QIAGEN N.V. and NeuMoDx Molecular, Inc. have formed a strategic alliance to market two innovative fully integrated PCR (polymerase chain reaction) testing devices. These next-generation technologies were created to aid clinical molecular diagnostic laboratories in their processing.
Quidel Corporation and Alere Inc. signed a formal agreement in 2017 to buy Triage MeterPro’s cardiovascular (CV) and toxicological assets, as well as the B-type Naturietic Peptide (BNP) test business.
Eurofins Scientific purchased Diatherix Labs, Inc. in 2015, which provides diagnostic laboratory solutions on a multiplexing platform for infectious illness diagnosis.
Table of Content
Global Virology Testing Market Research Report
Section 1: Global Virology Testing Industry Overview
Section 2: Global Economic Impact on Virology Testing Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Virology Testing Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Virology Testing Market Forecast
Other Exclusive Reports:
Middle East and Turkey Immune Thrombocytopenic Purpura (ITP) Treatment Drugs Market – https://www.openpr.com/news/2344267/huge-growth-expected-in-immune-thrombocytopenic-purpura-itp
Neurointerventional Devices Market – https://www.openpr.com/news/2344293/pdf-increasing-demand-for-neuro-interventional-devices
Safety Needles Market – https://www.openpr.com/news/2344311/pdf-trends-on-safety-needles-analysis-market-outlook-2021
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837